Drug Delivery Research: The Invention Cycle

Area of Science:

• Pharmaceutical Sciences
• Biotechnology
• Drug Delivery Systems

Background:

• Controlled drug delivery systems have advanced drug formulations but face challenges with large molecules like proteins and nucleic acids.
• Progress in drug delivery has plateaued over the last three decades, particularly for hydrophilic, high molecular weight biologics.
• Existing methods for small molecule delivery are inadequate for complex biologicals, necessitating new approaches.

Purpose of the Study:

• To propose a new framework, the "invention cycle," for developing next-generation drug delivery systems.
• To address the limitations in formulating and delivering biological drugs, such as proteins and nucleic acids.
• To guide the development of novel formulations for targeted, sustained, and pulsatile release of biologics.

Main Methods:

• Defining the "invention cycle" as a structured process for formulation development.
• Emphasizing problem definition, creative problem-solving, and innovation in developing new delivery systems.
• Highlighting the importance of the translational process for clinical application of new formulations.

Main Results:

• The proposed "invention cycle" offers a systematic approach to overcome challenges in biological drug delivery.
• This framework encourages examination of formulation successes, not solely failures.
• It advocates for new funding and recognition mechanisms for scientists to foster long-term innovation.

Conclusions:

• A structured "invention cycle" is crucial for advancing drug delivery systems, especially for biologics.
• Innovation in formulation development requires a shift towards addressing specific challenges of large molecules.
• The proposed cycle aims to accelerate the development and clinical translation of effective biological drug delivery systems.